Lighthouse Investment Partners’s BridgeBio Pharma BBIO Stock Holding History

Lighthouse Investment Partners’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,000	Closed	-$994K	–	738
2025 Q4	$994K	Buy	13,000 +3,800	+41%	+$249K	0.03%	481
2025 Q3	$478K	Sell	9,200 -5,000	-35%	-$244K	0.01%	521
2025 Q2	$613K	Buy	+14,200	New	+$516K	0.02%	432
2025 Q1	–	Sell	-125,000	Closed	-$3.43M	–	481
2024 Q4	$3.43M	Buy	+125,000	New	+$3.23M	0.11%	216
2024 Q2	–	Sell	-43,416	Closed	-$1.34M	–	405
2024 Q1	$1.34M	Buy	+43,416	New	+$1.48M	0.06%	265

Other funds holding BBIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lighthouse Investment Partners's BBIO Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of BridgeBio Pharma (BBIO) in Q1 2026, closing a stake of 13,000 shares — an estimated $994K sold.

Lighthouse Investment Partners first reported a position in BBIO in Q1 2024 and held it in 5 quarters. The position peaked at $3.43M in Q4 2024. 460 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

Lighthouse Investment Partners reported no remaining BridgeBio Pharma position as of Q1 2026 after selling out during the quarter.
Lighthouse Investment Partners sold 13,000 BridgeBio Pharma shares in Q1 2026, an estimated $994K.
Lighthouse Investment Partners first reported a position in BridgeBio Pharma in Q1 2024 and held it in 5 quarters.
Lighthouse Investment Partners's BridgeBio Pharma position peaked at $3.43M in Q4 2024.
460 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.